Catalog Number 1804275-23 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Hypersensitivity/Allergic reaction (1907); Swelling/ Edema (4577)
|
Event Date 10/27/2023 |
Event Type
Injury
|
Event Description
|
It was reported that a xience skypoint stent was implanted and some time later the patient experienced a potential allergic reaction.There were no reported adverse patient sequela.No additional information was provided.
|
|
Manufacturer Narrative
|
B3: date of procedure estimated as (b)(6) 2024.D4: the udi is unknown because the part/lot number were not provided.Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
|
|
Manufacturer Narrative
|
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of hypersensitivity and edema are listed in the xience skypoint everolimus eluting coronary stent systems instructions for use as known patient effects of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined; however, the subsequent treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.B3: date of procedure updated.B6 - relevant test/laboratory data updated.H6: medical device problem code 4614 removed and 4644, 4577 added.
|
|
Event Description
|
It was reported that a xience skypoint stent was implanted and some time later the patient experienced a potential allergic reaction.There were no reported adverse patient sequela.Subsequent to the initially filed report, it was reported that a 2.75x23 mm xience skypoint stent and a 2.25x12 mm xience skypoint stent were implanted in the distal left anterior descending (lad) coronary artery with mild tortuosity and 75% stenosis on (b)(6) 2023 and then the following symptoms began 2 weeks later: persistent urticaria and angioedema effecting face, neck, back, chest, arms.Antihistamines have been provided and the reaction is still present.No additional information was provided.
|
|
Search Alerts/Recalls
|